Showing results (111-120 of 143) with videos related to
Sort By:
Pageof 15
Blood Advances|September 28, 2021
Bilineal evolution of a U2AF1-mutated clone associated with acquisition of distinct secondary mutationsNathan D Montgomery, Jonathan Galeotti, Steven M Johnson, et al.Bioorganic & Medicinal Chemistry Letters|May 27, 2019
A high throughput substrate binding assay reveals hexachlorophene as an inhibitor of the ER-resident HSP70 chaperone GRP78Andrew J Ambrose, Christopher J Zerio, Jared Sivinski, et al.Genome Research|May 15, 2008
A high-resolution, nucleosome position map of C. elegans reveals a lack of universal sequence-dictated positioningAnton Valouev, Jeffrey Ichikawa, Thaisan Tonthat, et al.Bioorganic & Medicinal Chemistry Letters|May 18, 2016
GroEL/ES inhibitors as potential antibioticsSanofar Abdeen, Nilshad Salim, Najiba Mammadova, et al.Nutrients|June 4, 2020
Circulating and Adipose Tissue Fatty Acid Composition in Black South African Women with Obesity: A Cross-Sectional StudyPamela A Nono Nankam, Paul J van Jaarsveld, Elin Chorell, et al.Bioorganic & Medicinal Chemistry|November 10, 2022
Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosolSiddhi Chitre, Anne-Marie Ray, Mckayla Stevens, et al.Bioorganic & Medicinal Chemistry Letters|May 4, 2019
Dual-targeting GroEL/ES chaperonin and protein tyrosine phosphatase B (PtpB) inhibitors: A polypharmacology strategy for treating Mycobacterium tuberculosis infectionsAlex Washburn, Sanofar Abdeen, Yulia Ovechkina, et al.Leukemia & Lymphoma|November 3, 2023
Comprehensive genomic profiling reveals molecular subsets of ASXL1-mutated myeloid neoplasmsSteven M Johnson, James Haberberger, Jonathan Galeotti, et al.Biomedicines|October 29, 2025
Monocyte-Derived Macrophages Expressing Dopamine D2-Subtype Receptors Drive Alcohol Effects on Mesolimbic Neurons and MicrogliaChristina A Nelson, J Daniel Obray, Travis J Clarke, et al.Journal of Medicinal Chemistry|March 4, 2005
Bisaryloxime ethers as potent inhibitors of transthyretin amyloid fibril formationSteven M Johnson, H Michael Petrassi, Satheesh K Palaninathan, et al.Pageof 15